New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia

The treatment of acute myeloid leukemia (AML) has evolved over the past few years with the advent of next-generation sequencing. Targeted therapies alone or in combination with low-dose or high-intensity chemotherapy have improved the outcome of patients with AML treated in the frontline and relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohty, Razan, El Hamed, Rama, Brissot, Eolia, Bazarbachi, Ali, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890036/
https://www.ncbi.nlm.nih.gov/pubmed/36722403
http://dx.doi.org/10.3324/haematol.2022.280798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890036/
https://www.ncbi.nlm.nih.gov/pubmed/36722403
http://dx.doi.org/10.3324/haematol.2022.280798

Ejemplares similares